Bringing the fundamentals into focus…
Back to Arvinas, Inc.
How Arvinas, Inc. stacks up
ARVN · against 1,336 other Healthcare companies
Valuation
52/ 100
Above the middle of the pack.
Ranked #636 of 1,337 · scores higher than 52% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 50–59, including ARVN · Click a bar to see the companies
Why valuation scores 52?
Weighted metrics compared with all Healthcare companies.A mix: stronger earnings yield, but weaker free cash flow yield than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -45.0% vs peer median 0.0%
- higher earnings for the price paid: stronger than 68% of peers. Earnings yield: 2.0% vs peer median 1.5%
- Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.
Metric by metric
Position: dot = ARVN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.7% | 1.5% | 68% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 14.4% | 4.2% | 90% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -45.6% | -1.0% | 6% | 20% | |
| Book yieldHigher is better · 1,306 reported | 121.4% | 37.9% | 91% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ARVNScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score